Haleon plc (NYSE:HLN) Plans Semi-annual Dividend of $0.05

Haleon plc (NYSE:HLN) announced a semi-annual dividend on Friday, August 2nd, Wall Street Journal reports. Investors of record on Friday, August 16th will be given a dividend of 0.0514 per share on Thursday, September 19th. This represents a dividend yield of 1.6%. The ex-dividend date is Friday, August 16th.

Haleon has a payout ratio of 42.0% indicating that its dividend is sufficiently covered by earnings. Equities analysts expect Haleon to earn $0.51 per share next year, which means the company should continue to be able to cover its $0.21 annual dividend with an expected future payout ratio of 41.2%.

Haleon Price Performance

NYSE HLN traded up $0.30 on Friday, hitting $9.63. 6,974,554 shares of the company’s stock were exchanged, compared to its average volume of 5,223,962. Haleon has a 52 week low of $7.70 and a 52 week high of $9.73. The stock has a 50-day moving average of $8.61 and a 200-day moving average of $8.42. The company has a current ratio of 1.04, a quick ratio of 0.73 and a debt-to-equity ratio of 0.53. The stock has a market cap of $43.97 billion, a price-to-earnings ratio of 32.23, a P/E/G ratio of 2.63 and a beta of 0.24.

Haleon (NYSE:HLN) last released its quarterly earnings data on Thursday, August 1st. The company reported $0.08 earnings per share for the quarter, missing the consensus estimate of $0.09 by ($0.01). The business had revenue of $3.50 billion during the quarter, compared to analyst estimates of $3.55 billion. Haleon had a net margin of 9.68% and a return on equity of 13.17%. During the same period last year, the business earned $0.08 earnings per share. Analysts expect that Haleon will post 0.47 earnings per share for the current year.

Analyst Upgrades and Downgrades

A number of research firms recently issued reports on HLN. Berenberg Bank initiated coverage on shares of Haleon in a research report on Wednesday, June 5th. They set a “buy” rating for the company. HSBC began coverage on shares of Haleon in a report on Wednesday, April 17th. They set a “buy” rating for the company. One research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company’s stock. Based on data from MarketBeat, Haleon currently has an average rating of “Moderate Buy”.

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.